Clinical Trial Update: Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase I safety trial of a human anti-HIV immune serum globulin sponsored by Abbott.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Anti-HIV Immune Serum Globulin (Human) (Anti-HIV immune serum globulin (human))

Snippet

Sponsor: Abbott | Conditions: HIV Infections | Phase 1 | Status: COMPLETED